Dual inhibition of the renin–angiotensin system in high-risk diabetes and risk for stroke and other outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual inhibition of the renin–angiotensin system in high-risk diabetes and risk for stroke and other outcomes

Published:2013-02 Issue:2 Volume:31 Page:414-421
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Mann Johannes F.E.,Anderson Craig,Gao Peggy,Gerstein Hertzel C.,Boehm Michael,Rydén Lars,Sleight Peter,Teo Koon K.,Yusuf Salim

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference22 articles.

1. The management of the type 2 diabetic patient with hypertension: too late and too little: suggested improvements.;Ryden;Blood Press,2008

2. Effects of intensive blood-pressure control in type 2 diabetes mellitus.;Group;N Engl J Med,2010

3. Use of ramipril in preventing stroke: double blind randomised trial.;Bosch;BMJ,2002

4. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.;Parving;Nephrol Dial Transplant,2009

5. Telmisartan, ramipril, or both in patients at high risk for vascular events.;Investigators;N Engl J Med,2008

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

2. Influence of incomplete death information on cumulative risk estimates in US claims data;American Journal of Epidemiology;2024-04-06

3. Diabetic Nephropathy: Pathogenesis and Drug Delivery System;Research Journal of Pharmacy and Technology;2023-12-29

4. Comparison of angiotensin converting enzyme ınhibitor and/or angiotensin receptor blocker treatments of patients in 3 different patient groups with proteinuria;Turkish Journal of Clinics and Laboratory;2023-09-30

5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease;Cochrane Database of Systematic Reviews;2023-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3